Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 26 studies | 34% ± 18% | |
epithelial cell | 10 studies | 37% ± 19% | |
myofibroblast cell | 10 studies | 35% ± 15% | |
mesothelial cell | 9 studies | 59% ± 22% | |
secretory cell | 8 studies | 45% ± 18% | |
respiratory goblet cell | 7 studies | 45% ± 15% | |
connective tissue cell | 7 studies | 32% ± 12% | |
club cell | 6 studies | 38% ± 8% | |
basal cell | 6 studies | 28% ± 15% | |
ciliated cell | 5 studies | 39% ± 10% | |
adventitial cell | 5 studies | 59% ± 13% | |
goblet cell | 5 studies | 31% ± 18% | |
duct epithelial cell | 4 studies | 89% ± 5% | |
adipocyte | 4 studies | 17% ± 1% | |
glutamatergic neuron | 4 studies | 27% ± 11% | |
enterocyte | 3 studies | 21% ± 4% | |
transit amplifying cell | 3 studies | 19% ± 1% | |
serous secreting cell | 3 studies | 26% ± 2% | |
GABAergic neuron | 3 studies | 21% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 95% | 4343.22 | 548 / 578 | 87% | 63.74 | 1002 / 1155 |
bladder | 95% | 5768.81 | 20 / 21 | 78% | 233.84 | 391 / 504 |
prostate | 94% | 6851.92 | 231 / 245 | 75% | 44.76 | 378 / 502 |
ovary | 91% | 4349.47 | 163 / 180 | 77% | 93.44 | 333 / 430 |
intestine | 82% | 2038.27 | 792 / 966 | 76% | 49.15 | 398 / 527 |
breast | 80% | 3845.01 | 367 / 459 | 75% | 99.46 | 841 / 1118 |
uterus | 69% | 3013.76 | 118 / 170 | 65% | 156.79 | 299 / 459 |
esophagus | 60% | 1740.29 | 873 / 1445 | 63% | 48.31 | 115 / 183 |
pancreas | 27% | 368.37 | 88 / 328 | 92% | 124.44 | 163 / 178 |
stomach | 41% | 1704.27 | 146 / 359 | 68% | 33.71 | 195 / 286 |
kidney | 65% | 1824.57 | 58 / 89 | 43% | 29.76 | 391 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 55.34 | 1 / 1 |
lymph node | 0% | 0 | 0 / 0 | 93% | 47.11 | 27 / 29 |
adrenal gland | 72% | 1567.29 | 186 / 258 | 8% | 2.41 | 19 / 230 |
thymus | 66% | 1638.81 | 431 / 653 | 14% | 2.71 | 85 / 605 |
blood vessel | 70% | 2115.72 | 930 / 1335 | 0% | 0 | 0 / 0 |
adipose | 64% | 8542.51 | 776 / 1204 | 0% | 0 | 0 / 0 |
heart | 62% | 2790.15 | 538 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 60% | 26.65 | 27 / 45 |
skin | 10% | 103.00 | 179 / 1809 | 46% | 17.13 | 218 / 472 |
liver | 8% | 81.47 | 18 / 226 | 26% | 13.16 | 105 / 406 |
muscle | 12% | 156.60 | 99 / 803 | 0% | 0 | 0 / 0 |
brain | 0% | 1.82 | 3 / 2642 | 10% | 6.02 | 68 / 705 |
spleen | 8% | 70.12 | 19 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.29 | 2 / 80 |
peripheral blood | 1% | 21.79 | 10 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
GO_0008191 | Molecular function | metalloendopeptidase inhibitor activity |
Gene name | RARRES1 |
Protein name | Retinoic acid receptor responder protein 1 (Phorbol ester-induced gene 1 protein) (PERG-1) (RAR-responsive protein TIG1) (Tazarotene-induced gene 1 protein) |
Synonyms | TIG1 PEIG1 |
Description | FUNCTION: Inhibitor of the cytoplasmic carboxypeptidase AGBL2, may regulate the alpha-tubulin tyrosination cycle. . |
Accessions | P49788 ENST00000237696.10 [P49788-1] ENST00000479756.1 [P49788-2] |